- Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
-
Compounds of formula (I): wherein: m and n represent 1 or 2,A represents a pyrrolyl group,X represents a C(O), S(O) or SO2 group,R1 and R2 represent an alkyl group or, together with the nitrogen atom carrying them, form a heterocyclic group,R3 and R4, together with the atoms carrying them, form a heterocyclic group,R5 represents a hydrogen atom or an alkyl group,R6 represents a hydrogen atom or a halogen atom. Medicinal products containing the same which are useful in treating cancer.
- -
-
Page/Page column 16
(2011/02/26)
-
- Substituted 5-Phenyl-3,6-Dihydro-2-Oxo-6H-1,3,4-Thiadiazines
-
Compounds of the formula (I), in which R1, R2, m, Q and B have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours.
- -
-
Page/Page column 18
(2009/01/24)
-
- 3, 6-Dihydro-2-Oxo-6H-1,3,4,-Thiadiazine Derivatives
-
Compounds of the formula I, in which R1, R2, Q and B have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours.
- -
-
Page/Page column 17-18
(2009/01/20)
-